Dermira, Inc. is a biopharmaceutical company, which engages in the provision of therapies for chronic skin conditions. It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis and atopic dermatitis. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Menlo Park, CA.
Company profile
Website
CEO
Thomas G. Wiggans
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Latest filings (excl ownership)
15-12B
Securities registration termination
2 Mar 20
EFFECT
Notice of effectiveness
25 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 20
POSASR
Automatic shelf registration (post-effective amendment)
20 Feb 20
POS AM
Prospectus update (post-effective amendment)
20 Feb 20
Latest ownership filings
SC 13G/A
PFM Health Sciences, LP
16 Feb 21
SC 13G/A
BlackRock Inc.
9 Mar 20
4
Jason Raleigh Nunn
24 Feb 20
4
ANDREW GUGGENHIME
24 Feb 20
4
MARK MCDADE
24 Feb 20
4
Matthew K Fust
24 Feb 20
4
Lori Lyons-Williams
24 Feb 20
4
Daljit Singh Aurora
24 Feb 20
4
Christopher Horan
24 Feb 20
4
EUGENE A BAUER
24 Feb 20
Institutional ownership, Q3 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|